Joachim Foerderer will hand over the chairmanship of the Management Board to Baldassare La Gaetana
Aarbergen, 26 April 2018 – The shareholders and management of the Aqseptence Group GmbH officially announced yesterday that Mr. Joachim Foerderer (54) would step down from his management position of CEO as of 31 May 2018. He had already informed internally that he would not take the option to extend his contract by five years as CEO several months ago. Mr. Foerderer will join the company’s Advisory Board on 1 June 2018 and exercise the management company’s voting rights. Mr. Baldassare La Gaetana (35), who has been a member of the Management Board of Aqseptence Group GmbH since 2015 and has been a member of the Group since 2008, has been appointed as his successor in the position of CEO.
In addition, Mr. Rudolf Bogner will leave his management position on 31 July 2018 to concentrate exclusively on his position as CEO of cnp-Technology Water and Biosolids GmbH.
Wu Yang, representing the Aqseptence Group shareholders: “We very much thank Mr. Foerderer and appreciate his contribution over the past years. We are really pleased that during the last years he has supported Mr. La Gaetana in such a targeted way that we succeeded in filling the position internally. We are looking forward to continued cooperation with Mr. Foerderer on the Advisory Board as well as in joint shareholder meetings and would like to thank him for his exceptionally successful work and the impressive development of the Group over the period of his long-standing leadership.”
Joachim Foerderer: “It is the perfect time to hand over the CEO’s baton in the coming weeks and to remain closely associated with the Aqseptence Group as a representative of the management company and co-investor, and to have the opportunity to start something completely new. All the more so as I am convinced that the Aqseptence Group with my longstanding colleagues – Baldassare La Gaetana (future CEO), Mark Stegmayer (CFO) and Rosario E. Tagliavini (COO) – is in an excellent position.”
In the 2017 financial year, the Aqseptence Group generated one of its best results with a consolidated EBT (IFRS) of approximately EUR 20 million. In addition, the first quarter of 2018 closed with an increase in earnings compared to the same period last year. The Aqseptence Group’s order backlog has also developed very positively. Mr Foerderer will continue to be available to the Management Board in an advisory capacity even after his resignation.